Loading...
Loading...
India's nivolumab imports from NORWAY total $590 across 3 shipments from 1 foreign suppliers. ABACUS MEDICINE PHARMA SERVICES LIMITED leads with $590 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include RELIANCE LIFE SCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for nivolumab — a concentrated sourcing relationship with select suppliers from NORWAY.

ABACUS MEDICINE PHARMA SERVICES LIMITED is the leading Nivolumab supplier from NORWAY to India, with import value of $590 across 3 shipments. The top 5 suppliers — ABACUS MEDICINE PHARMA SERVICES LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ABACUS MEDICINE PHARMA SERVICES LIMITED | $590 | 3 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $590 | 3 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Nivolumab suppliers from NORWAY to India include ABACUS MEDICINE PHARMA SERVICES LIMITED. The leading supplier is ABACUS MEDICINE PHARMA SERVICES LIMITED with import value of $590 USD across 3 shipments. India imported Nivolumab worth $590 USD from NORWAY in total across 3 shipments.
India imported Nivolumab worth $590 USD from NORWAY across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Nivolumab sourced from NORWAY include RELIANCE LIFE SCIENCES PRIVATE LIMITED. The largest buyer is RELIANCE LIFE SCIENCES PRIVATE LIMITED with $590 in imports across 3 shipments.
The total value of Nivolumab imports from NORWAY to India is $590 USD, across 3 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists